7Baggers

Rocket Lab Quarterly Cash Flow Statements Chart

Quarterly
 | 
Annual
 
 Stock-Based Compensation  
 Operating Cash Flow  
 Investing Cash Flow  
 Financing Cash Flow  
 Free Cash Flow  
 Capital Expenditure  
20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 -72.45-59.35-46.26-33.16-20.06-6.966.1419.23Milllion

Rocket Lab Quarterly Cash Flow Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                    
  cash flows from operating activities:                  
  net income-66,414,000 -60,616,000 -52,345,000 -51,939,000 -41,631,000 -44,260,000 -50,497,000 -40,568,000 -45,889,000 -45,617,000 -37,208,000 -34,610,000 -37,417,000 -26,709,000 3,196,000 -119,456,906 22,501,169 -23,560,263 
  adjustments to reconcile net income to net cash from operating activities:                  
  depreciation and amortization8,758,000 8,707,000 9,139,000 8,095,000 8,108,000 8,313,000 8,167,000 7,792,000 6,752,000 7,033,000 8,357,000 7,853,000 7,649,000 6,088,000 3,441,000    
  stock-based compensation expense17,933,000 19,234,000 16,872,000 12,896,000 13,955,000 13,093,000 10,063,000 14,098,000 15,264,000 14,036,000 12,337,000 14,485,000 16,869,000 11,958,000     
  gain on disposal of assets                  
  loss on extinguishment of long-term debt  1,330,000             
  amortization of debt issuance costs and discount860,000 831,000 819,000 818,000 815,000 639,000 738,000 735,000 722,000 709,000 720,000 715,000 702,000 690,000 700,000    
  noncash lease expense2,046,000 1,519,000 1,514,000 1,478,000 1,468,000 1,491,000 1,725,000 2,036,000 1,038,000 988,000 887,000 786,000 795,000 731,000 531,000    
  change in the fair value of contingent consideration  53,000 -271,000 205,000 -462,000 1,300,000 300,000    2,500,000     
  accretion of marketable securities purchased at a discount-538,000 -561,000 -629,000 -667,000 -763,000 -842,000 -1,172,000 -1,283,000 -969,000 -1,147,000 -974,000        
  deferred income taxes2,039,000 -585,000 -1,711,000 310,000 1,922,000 78,000 64,000 396,000 -172,000 420,000 -1,743,000 916,000 1,809,000 -1,558,000 -6,272,000    
  changes in operating assets and liabilities:                  
  accounts receivable-22,343,000 -2,974,000 -14,356,000 28,348,000 -19,359,000 3,939,000 -12,346,000 2,365,000 25,549,000 -14,116,000 21,322,000 -17,826,000 -7,282,000 -5,644,000 2,812,000    
  contract assets9,028,000 2,165,000 -13,651,000 -30,717,000 -3,849,000 -1,944,000 91,000 3,672,000 -4,155,000 -3,109,000 -585,000 -4,674,000 1,382,000 -3,668,000 -153,000    
  inventories-5,205,000 -6,308,000 -5,280,000 -9,648,000 -4,979,000 7,509,000 -4,629,000 -322,000 -3,899,000 -6,712,000 -8,329,000 -1,333,000 -7,170,000 -9,132,000 -462,000    
  prepaids and other current assets-8,420,000 -9,617,000 5,640,000 6,589,000 665,000 -5,303,000 1,233,000 -4,980,000 -804,000 -10,035,000 2,114,000 -9,083,000 -7,019,000 -1,071,000 -8,633,000    
  other non-current assets10,308,000 1,571,000 -13,466,000 5,833,000 -1,023,000 -4,266,000 -758,000 -5,078,000 -5,737,000 103,000 -10,353,000 1,192,000 1,317,000 772,000     
  trade payables1,370,000 9,779,000 10,947,000 15,783,000 -257,000 -1,673,000 3,559,000 -1,208,000 1,929,000 11,305,000 -504,000 -3,617,000 1,187,000 805,000 -20,000    
  accrued expenses6,736,000 -2,712,000 6,106,000 -3,586,000 3,366,000 3,200,000 -1,088,000 658,000 -3,248,000 403,000 12,000 -97,000 -188,000 -3,245,000 305,000    
  employee benefits payables3,542,000 -253,000  4,589,000 -442,000 -622,000 199,000 1,169,000 2,822,000 1,294,000 -411,000 -1,406,000 3,450,000 475,000 -1,560,000    
  contract liabilities16,511,000 -9,294,000 49,074,000 -16,927,000 33,513,000 11,205,000 5,542,000 -780,000 8,938,000 17,292,000 -3,743,000 21,937,000 -6,185,000 10,652,000 3,026,000    
  other current liabilities3,797,000 -3,699,000 -839,000 -134,000 -2,507,000 6,729,000 -2,931,000 -2,751,000 -4,186,000 2,305,000 -1,030,000 2,878,000 -4,834,000 4,266,000 930,000    
  non-current lease liabilities-4,877,000 -1,670,000 -2,084,000 -1,461,000 -1,435,000 -1,425,000 -1,760,000 -1,374,000 -1,051,000 -891,000 -1,135,000 -911,000 -857,000 -783,000 -543,000    
  other non-current liabilities137,000 245,000 556,000 589,000 575,000 489,000 -3,000 471,000 -290,000 49,000 629,000 12,000 16,000 11,000 373,000    
  net cash from operating activities-23,242,000 -54,225,000 -2,387,000 -30,915,000 -13,000,000 -2,588,000 -42,217,000 -25,201,000 -6,064,000 -25,385,000 -18,946,000 -22,997,000 -38,256,000 -26,339,000 -21,914,000    
  capex-28,483,000 -18,227,000 -21,554,000 -11,178,000 -14,618,000 -17,597,000 -10,414,000 -20,983,000 -9,353,000 -11,750,000 -14,993,000 -6,900,000 -13,218,000 -4,825,000 -14,199,000    
  free cash flows-51,725,000 -72,452,000 -23,941,000 -42,093,000 -27,618,000 -20,185,000 -52,631,000 -46,184,000 -15,417,000 -37,135,000 -33,939,000 -29,897,000 -51,474,000 -31,164,000 -36,113,000    
  cash flows from investing activities:                  
  purchases of property, equipment and software-32,042,000 -28,677,000 -21,554,000 -11,018,000 -15,344,000 -19,177,000 -10,414,000 -21,047,000 -10,572,000 -12,674,000 -14,993,000 -8,349,000 -12,828,000 -6,242,000 -14,252,000    
  proceeds on disposal of assets128,000 16,000 786,000 941,000               
  purchases of marketable securities-43,686,000 -84,639,000 -12,613,000 -36,274,000 -33,915,000 -79,359,000 -75,266,000 -55,606,000 -76,394,000 -79,714,000        
  maturities of marketable securities64,796,000 84,699,000 13,312,000 29,047,000 27,603,000 46,280,000 49,864,000 65,164,000 76,077,000 78,099,000         
  sale of marketable securities                  
  net cash from investing activities-7,421,000 -28,601,000 -17,926,000 -17,304,000 -10,841,000 -52,256,000 61,171,000 -31,964,000 -6,220,000 -10,969,000 -73,223,000 -188,713,000 -12,313,000 -71,830,000 -80,687,000    
  cash flows from financing activities:                  
  proceeds from atm equity offering303,841,000 92,806,000                 
  issuance costs related to atm equity offering-7,408,000 -2,088,000                 
  proceeds from the exercise of stock options331,000 48,000                 
  proceeds from employee stock purchase plan2,599,000 2,237,000 1,585,000 1,433,000 2,158,000 507,000 1,208,000 1,258,000 1,320,000 1,202,000 1,231,000 1,058,000 1,066,000 1,025,000     
  proceeds from sale of employees restricted stock units to cover taxes23,405,000 17,310,000 20,263,000 5,721,000 4,151,000 5,119,000 3,605,000 4,589,000 4,723,000 3,078,000 2,579,000 4,585,000 3,161,000 20,841,000     
  minimum tax withholding paid on behalf of employees for restricted stock units-23,844,000 -16,577,000 -20,167,000 -5,690,000 -4,316,000 -5,163,000 -3,370,000 -5,384,000 -5,053,000 -1,915,000 -2,856,000 -4,567,000 -14,985,000 -8,756,000     
  purchase of capped calls related to issuance of convertible senior notes  -43,168,000             
  proceeds from issuance of convertible senior notes  355,000,000             
  proceeds from secured term loan25,000,000                 
  repayments on secured term loan-8,314,000 -2,894,000                 
  payment of debt issuance costs-278,000 -979,000 -11,226,000             
  finance lease principal payments-65,000 -61,000 -60,000 208,000 -387,000 -90,000 -88,000 -88,000 -82,000 -78,000 -78,000 -77,000 -71,000 -45,000     
  net cash from financing activities290,545,000 115,503,000 183,000 -444,000 -1,764,000 258,707,000 2,506,000 860,000 1,945,000 2,058,000 472,000 2,135,000 -15,010,000 14,444,000 -1,840,000    
  effect of exchange rate changes on cash and cash equivalents855,000 272,000 -1,360,000 904,000 378,000 -519,000 482,000 43,000 -609,000 127,000 1,281,000 -767,000 4,432,000 -574,000 2,727,000    
  net increase in cash and cash equivalents and restricted cash260,737,000 32,949,000 -21,490,000 -47,759,000 -25,227,000 203,344,000     -90,416,000 -210,342,000   -101,714,000    
  cash and cash equivalents, and restricted cash, beginning of period275,302,000 166,434,000 245,871,000 692,075,000    
  cash and cash equivalents, and restricted cash, end of period260,737,000 308,251,000 -21,490,000 -47,759,000 -25,227,000 369,778,000 21,942,000 -56,262,000 -10,948,000 211,702,000 -90,416,000 -210,342,000 -61,147,000 607,776,000 -101,714,000    
  supplemental disclosure of cash flow information:                  
  cash paid for interest2,724,000 9,575,000  9,650,000 2,318,000 2,270,000  3,690,000 3,634,000 3,417,000  2,823,000 2,479,000 2,292,000 2,069,000    
  cash paid for income taxes214,000 214,000  77,000 377,000 26,000  187,000 72,000 315,000  490,000 -220,000 2,248,000     
  supplemental disclosure of noncash investing and financing activities:                  
  unpaid purchases of property, equipment and software3,559,000 10,450,000  -160,000 726,000 1,580,000  64,000 1,219,000 924,000  1,449,000 -390,000 1,417,000 53,000    
  right-of-use assets obtained in exchange for new operating lease liabilities19,423,000 179,000      71,000 908,000  2,560,000 3,783,000 3,567,000    
  issuance of common stock for payment of accrued bonus   1,795,000      1,441,000     
  accrued issuance costs in connection with atm equity offering-527,000 615,000                 
  common stock issued in acquisition, at fair value                 
  loss on disposal of assets 13,000    3,000  213,000 22,000 5,000 891,000 7,000 20,000 5,000 93,000    
  accrued debt issuance costs     979,000             
  (gain) loss on disposal of assets  -472,000 -1,164,000               
  noncash income associated with liability-classified warrants          -13,482,000     
  employee benefits payable                  
  cash paid for business combinations and asset acquisitions, net of acquired cash and restricted cash      -2,032,000 -815,000           
  proceeds from the exercise of stock options and public warrants    216,000 943,000 151,000 485,000 1,037,000 771,000 -404,000 1,136,000 1,763,000 1,379,000     
  tax payment for net settled option shares                
  payment of contingent consideration      -1,000,000       
  repayments on secured term loans                  
  cash paid for asset acquisition                  
  repayments on trinity loan agreement   -3,031,000 -2,607,000 -43,215,000             
  unpaid transaction costs              -2,214,000    
  proceeds from revolving line of credit                  
  repayments on revolving line of credit                  
  proceeds from business combination and pipe investment, net of transaction costs              -2,197,000    
  repurchase of shares and options from management, net of amount recognized as compensation cost                  
  net decrease in cash and cash equivalents and restricted cash       -56,262,000 -10,948,000 -34,169,000    -84,299,000     
  common stocks issued in acquisition, at fair value                  
  net exercise of public and private warrants into common stock           44,739,000     
  cash paid for acquisitions, net of acquired cash and restricted cash                 
  proceeds from long-term revolving line of credit                 
  proceeds from long-term secured term loan                 
  repayments on long-term revolving line of credit                 
  net proceeds from issuance of series e-1 preferred stock                  
  repayments of marketable securities                  
  warrants assumed as part of business combination                 
  prepaid expenses assumed as part of business combination              33,000    
  cash paid for acquisition, net of acquired cash and restricted cash            515,000 -65,588,000     
  payment of deferred transaction costs associated with planned reverse recapitalization transaction                  
  supplemental disclosures of cash flow information:                  
  deferred transaction costs in accrued expenses                  
  stock compensation expense              8,384,000    
  amortization of inventory step-up                  
  loss on debt extinguishment                 
  noncash expense associated with liability-classified warrants              -24,130,000    
  cash paid for acquisitions, net of acquired cash                  
  repurchase of shares and options from management                 
  cash refunds/(paid) for income taxes                  
  issuance of common stock warrants and accrued issuance costs in connection with loan and security agreement                  
  issuance of common stock in connection with acquisition, at fair value                  
  contingent consideration assumed at acquisitions                  
  cash paid for acquisition, net of acquired cash                  
  redeemable class a ordinary shares                  
  numerator: earnings allocable to redeemable class a ordinary shares                  
  interest income                53 4,810 
  redeemable net earnings                9,673 -4,810 
  denominator: weighted-average redeemable class a ordinary shares                  
  redeemable class a ordinary shares, basic and diluted                32,000,000 
  earnings/basic and diluted redeemable class a ordinary shares                
  non-redeemable class b ordinary shares                  
  numerator: net income minus redeemable net earnings                  
  less: redeemable net earnings                  
  non-redeemable net income                22,501,116 -23,565,073 
  denominator: weighted-average non-redeemable class b ordinary shares                  
  non-redeemable class b ordinary shares, basic and diluted                8,000,000 
  loss/basic and diluted non-redeemable class b ordinary shares                2.82 -2.95 
  net earnings                 4,810 

We provide you with 20 years of cash flow statements for Rocket Lab stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Rocket Lab stock. Explore the full financial landscape of Rocket Lab stock with our expertly curated income statements.

The information provided in this report about Rocket Lab stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.